DCM
EIDX

Driehaus Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Driehaus Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-229,650
Closed -$11.3M – 506
2020
Q1 		$11.3M Buy
229,650
+12,294
+6% +$602K 0.38% 74
2019
Q4 		$12.5M Buy
+217,356
New +$12.5M 0.33% 88